Literature DB >> 15670750

The role of apolipoprotein E in the elimination of liposomes from blood by hepatocytes in the mouse.

Xuedong Yan1, Folkert Kuipers, Louis M Havekes, Rick Havinga, Bert Dontje, Klaas Poelstra, Gerrit L Scherphof, Jan A A M Kamps.   

Abstract

We evaluated the role of apolipoprotein E (apoE) in the clearance of neutral and negatively charged liposomes by hepatocytes in apoE-deficient mice. Negatively charged liposomes were cleared at identical rates in apoE-deficient and wild-type mice; neutral liposomes were cleared at a 3.6-fold slower rate in apoE-deficient mice. ApoE deficiency did not affect hepatic uptake of negatively charged liposomes but lowered that of neutral liposomes >5-fold. Hepatocyte uptake of neutral liposomes was reduced >20-fold in apoE-deficient mice; that of negatively charged liposomes remained unchanged. We conclude that uptake of neutral liposomes by hepatocytes is nearly exclusively apoE-mediated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15670750     DOI: 10.1016/j.bbrc.2004.12.137

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

Review 1.  Treating metastatic cancer with nanotechnology.

Authors:  Avi Schroeder; Daniel A Heller; Monte M Winslow; James E Dahlman; George W Pratt; Robert Langer; Tyler Jacks; Daniel G Anderson
Journal:  Nat Rev Cancer       Date:  2011-12-23       Impact factor: 60.716

2.  Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo.

Authors:  Nidhi Jyotsana; Amit Sharma; Anuhar Chaturvedi; Ramachandramouli Budida; Michaela Scherr; Florian Kuchenbauer; Robert Lindner; Fatih Noyan; Kurt-Wolfram Sühs; Martin Stangel; Denis Grote-Koska; Korbinian Brand; Hans-Peter Vornlocher; Matthias Eder; Felicitas Thol; Arnold Ganser; R Keith Humphries; Euan Ramsay; Pieter Cullis; Michael Heuser
Journal:  Ann Hematol       Date:  2019-05-18       Impact factor: 3.673

Review 3.  Nanoparticle ligand presentation for targeting solid tumors.

Authors:  Jason T Duskey; Kevin G Rice
Journal:  AAPS PharmSciTech       Date:  2014-06-14       Impact factor: 3.246

4.  Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms.

Authors:  Akin Akinc; William Querbes; Soma De; June Qin; Maria Frank-Kamenetsky; K Narayanannair Jayaprakash; Muthusamy Jayaraman; Kallanthottathil G Rajeev; William L Cantley; J Robert Dorkin; James S Butler; Liuliang Qin; Timothy Racie; Andrew Sprague; Eugenio Fava; Anja Zeigerer; Michael J Hope; Marino Zerial; Dinah W Y Sah; Kevin Fitzgerald; Mark A Tracy; Muthiah Manoharan; Victor Koteliansky; Antonin de Fougerolles; Martin A Maier
Journal:  Mol Ther       Date:  2010-05-11       Impact factor: 11.454

Review 5.  Nanovehicular intracellular delivery systems.

Authors:  Ales Prokop; Jeffrey M Davidson
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

6.  Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance.

Authors:  Dmitri Simberg; Ji-Ho Park; Priya P Karmali; Wan-Ming Zhang; Sergei Merkulov; Keith McCrae; Sangeeta N Bhatia; Michael Sailor; Erkki Ruoslahti
Journal:  Biomaterials       Date:  2009-04-26       Impact factor: 12.479

7.  Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes.

Authors:  Norbert Pardi; Steven Tuyishime; Hiromi Muramatsu; Katalin Kariko; Barbara L Mui; Ying K Tam; Thomas D Madden; Michael J Hope; Drew Weissman
Journal:  J Control Release       Date:  2015-08-08       Impact factor: 9.776

8.  Lactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma.

Authors:  Mengzi Zhang; Xiaoju Zhou; Bo Wang; Bryant C Yung; Ly J Lee; Kalpana Ghoshal; Robert J Lee
Journal:  J Control Release       Date:  2013-04-06       Impact factor: 9.776

9.  Relationship Between the Physicochemical Properties of Lipid Nanoparticles and the Quality of siRNA Delivery to Liver Cells.

Authors:  Yusuke Sato; Hiroto Hatakeyama; Mamoru Hyodo; Hideyoshi Harashima
Journal:  Mol Ther       Date:  2015-12-18       Impact factor: 11.454

10.  Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo.

Authors:  Muthusamy Jayaraman; Steven M Ansell; Barbara L Mui; Ying K Tam; Jianxin Chen; Xinyao Du; David Butler; Laxman Eltepu; Shigeo Matsuda; Jayaprakash K Narayanannair; Kallanthottathil G Rajeev; Ismail M Hafez; Akin Akinc; Martin A Maier; Mark A Tracy; Pieter R Cullis; Thomas D Madden; Muthiah Manoharan; Michael J Hope
Journal:  Angew Chem Int Ed Engl       Date:  2012-07-10       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.